China Primate SCNT Substrate Monopoly (CAS Shanghai, 2018-)
mechanismNations & Geopolitics · Media & Managed Opposition
One Chinese state lab now has a near-exclusive ability to mass-produce identical cloned monkeys for brain and drug research — and the West can't legally keep up.
Who they are
A cloning program at the Chinese Academy of Sciences' neuroscience institute in Shanghai, running since 2018[1].
What they do
It cracked the hard problem of cloning primates and built the only pipeline that can churn out genetically identical monkeys for brain-disease and pharmaceutical research. The engine is careful to say this is NOT a story of a new top power taking over.
How it works
In 2018 they made the first cloned macaques (Zhong Zhong and Hua Hua) using fetal cells plus chemicals that reset the cells; in 2024 they cloned a rhesus monkey (Retro) with a new placenta-fixing trick; in 2025 they launched a state-funded 25-year primate brain-mapping project. Western labs stay out because of ethics and regulation.
Why it matters
It shows one country cornering a rare research tool, not by conquering anyone but by being the only one willing and able to build it — a state-strategy advantage others simply don't contest.
The engine's record — word for word
**Jan 2018:** CAS Institute of Neuroscience Shanghai announces Zhong Zhong + Hua Hua, first SCNT-cloned macaques. Overcame primate-nuclear epigenetic-reprogramming resistance via fetal-fibroblast source cells + injected epigenetic modulators. **2024:** Retro, first SCNT-cloned rhesus monkey, born via trophoblast-replacement method to overcome placental defects. **2025:** International Consortium for Primate Brain Mapping (ICPBM) launched — 25-year initiative for multiomic primate-brain atlases, heavily state-subsidized. Engine framing: NOT a 'successor power' narrative (Technate node-framing binding). The pattern is substrate monopolization — CAS now possesses exclusive infrastructure to mass-produce genetically identical primate models for neurodegenerative disease research + pharmaceutical pipelines. Western competition absent due to ethical / regulatory constraints. Apex (a) Coordinated-state-strategic-research load-bearing.
Follow the trail
Walk this on the live map →